Castanea sativa
Species
KNApSAcK Entry
| Organism name | Castanea sativa |
|---|---|
| Genus | Castanea |
| Family | Fagaceae |
| Kingdom | Plantae |
NCBI taxonomy
Entry
| Linked NCBI taxonomy name | Castanea sativa |
|---|---|
| Linked NCBI taxonomy ID | 21020 |
| Linked level | species |
Family
| Family in NCBI taxonomy | Fagaceae |
|---|---|
| ID | 3503 |
Kingdom (Superkingdom)
| Kingdom (Superkingdom) in NCBI taxonomy | Viridiplantae |
|---|---|
| ID | 33090 |
Plant class
| Plant class | rosids |
|---|---|
| ID | 71275 |
Metabolite list (3)
| KNApSAcK ID | name | ChEMBL link | CTD link |
# of proteins in
ChEMBL interaction / related OMIM / related KEGG DISEASE |
# of genes in
CTD interaction / related diseases |
KCF-S
cluster |
phytochemical
cluster |
figure |
|---|---|---|---|---|---|---|---|---|
C00005883
|
Kaempferol 3-rhamnosyl-(1->6)(2''-p-coumarylglucoside)
|
No. 7 | No. 15 |
|
||||
|
C00005961
|
Helichrysoside
|
CHEMBL437553
|
C084710
|
No. 30 | No. 15 |
|
||
|
C00002868
|
Vitamin K1
/ Phylloquinone / Vitamin K1(20) / trans-Phylloquinone |
CHEMBL1550
CHEMBL520156 CHEMBL2024140 |
D010837
|
10 / 3 / 4 | 11 / 7 | No. 6845 |
|
Human Protein / Gene in interactions
10 ChEMBL Protein in interactions
| accession | description | class description | KNApSAcK metabolite in interactions |
# of diseases
(OMIM / KEGG) |
|---|---|---|---|---|
| O75469 | Nuclear receptor subfamily 1 group I member 2 | NR1I2 | C00002868 | 0 / 0 |
| P11473 | Vitamin D3 receptor | NR1I1 | C00002868 | 2 / 3 |
| P14902 | Indoleamine 2,3-dioxygenase 1 | Enzyme | C00002868 | 0 / 0 |
| Q92830 | Histone acetyltransferase KAT2A | Enzyme | C00002868 | 0 / 0 |
| O75496 | Geminin | Unclassified protein | C00002868 | 0 / 0 |
| Q9Y253 | DNA polymerase eta | Enzyme | C00002868 | 1 / 1 |
| P83916 | Chromobox protein homolog 1 | Unclassified protein | C00002868 | 0 / 0 |
| O94782 | Ubiquitin carboxyl-terminal hydrolase 1 | Enzyme | C00002868 | 0 / 0 |
| Q9UNA4 | DNA polymerase iota | Enzyme | C00002868 | 0 / 0 |
| Q96KQ7 | Histone-lysine N-methyltransferase EHMT2 | Enzyme | C00002868 | 0 / 0 |
11 Gene in CTD interactions
| gene | gene name | gene description | KNApSAcK metabolite in interactions |
|---|---|---|---|
| 596 | BCL2, Bcl-2, PPP1R50 | B-cell CLL/lymphoma 2 |
C00002868
|
| 637 | BID, FP497 | BH3 interacting domain death agonist |
C00002868
|
| 836 | CASP3, CPP32, CPP32B, SCA-1 | caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) |
C00002868
|
| 841 | CASP8, ALPS2B, CAP4, Casp-8, FLICE, MACH, MCH5 | caspase 8, apoptosis-related cysteine peptidase (EC:3.4.22.61) |
C00002868
|
| 8529 | CYP4F2, CPF2 | cytochrome P450, family 4, subfamily F, polypeptide 2 (EC:1.14.13.30) |
C00002868
|
| 2147 | F2, PT, RPRGL2, THPH1 | coagulation factor II (thrombin) (EC:3.4.21.5) |
C00002868
|
| 356 | FASLG, ALPS1B, APT1LG1, APTL, CD178, CD95-L, CD95L, FASL, TNFSF6 | Fas ligand (TNF superfamily, member 6) |
C00002868
|
| 2353 | FOS, AP-1, C-FOS, p55 | FBJ murine osteosarcoma viral oncogene homolog |
C00002868
|
| 3725 | JUN, AP-1, AP1, c-Jun | jun proto-oncogene |
C00002868
|
| 5594 | MAPK1, ERK, ERK2, ERT1, MAPK2, P42MAPK, PRKM1, PRKM2, p38, p40, p41, p41mapk | mitogen-activated protein kinase 1 (EC:2.7.11.24) |
C00002868
|
| 5595 | MAPK3, ERK-1, ERK1, ERT2, HS44KDAP, HUMKER1A, P44ERK1, P44MAPK, PRKM3, p44-ERK1, p44-MAPK | mitogen-activated protein kinase 3 (EC:2.7.11.24) |
C00002868
|
Related Diseases
Diseases related to proteins in ChEMBL interactions
Diseases related to CTD interactions
7 disease in interactions with metabolites
| MESH or OMIM | name |
KNApSAcK
metabolite |
|---|---|---|
| D002114 | Calcinosis |
C00002868
|
| D002543 | Cerebral Hemorrhage |
C00002868
|
| D003875 | Drug Eruptions |
C00002868
|
| D004485 | Eczema |
C00002868
|
| D006406 | Hematoma |
C00002868
|
| D006973 | Hypertension |
C00002868
|
| D012594 | Scleroderma, Localized |
C00002868
|